Add-on Acquisition • Life Science

Medix Biochemica Acquires Candor

On January 22, 2025, Medix Biochemica acquired life science company Candor

Acquisition Context

This is Medix Biochemica’s 3rd transaction in the Life Science sector.
This is Medix Biochemica’s 1st transaction in Germany.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	January 22, 2025
Target	Candor
Sector	Life Science
Buyer(s)	Medix Biochemica
Deal Type	Add-on Acquisition

Target Company

Candor

Wangen, Germany

Candor is a provider of a comprehensive selection of premium solutions for immunoassays, including HAMA and interference blockers, surface blockers, stabilizers, and buffer solutions. Candor was founded in 2004 and is based in Wangen, Germany.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Medix Biochemica

Espoo, Finland

Category	Company
Founded	1985
Sector	Life Science
Employees	267
Revenue	70M EUR (2023)

DESCRIPTION

Medix Biochemica develops, manufactures, and markets critical raw materials including antibodies, antigens, and biologicals for IVD companies worldwide. Medix Biochemica was founded in 1985 and is based in Espoo, Finland.

Deal Context for Buyer	#
Overall	3 of 3
Sector: Life Science	3 of 3
Type: Add-on Acquisition	3 of 3
Country: Germany	1 of 1
Year: 2025	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2023-11-10	ViroStat Westbrook, Maine, United States ViroStat is a primary manufacturer of infectious disease antibodies and antigens, supplying manufacturers and researchers. ViroStat was founded in 1985 and is based in Westbrook, Maine.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2023-11-10

ViroStat

Westbrook, Maine, United States

ViroStat is a primary manufacturer of infectious disease antibodies and antigens, supplying manufacturers and researchers. ViroStat was founded in 1985 and is based in Westbrook, Maine.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Germany M&A - 2025 M&A